Page last updated: 2024-12-05

2-chloroquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11928
CHEMBL ID2042580
SCHEMBL ID7252
MeSH IDM0222777

Synonyms (45)

Synonym
EU-0033663
AC-2439
einecs 210-317-8
brn 0112561
ccris 3977
ai3-08909
nsc 6163
EN300-20994
2-chloroquinoline ,
612-62-4
nsc-6163
nsc6163
quinoline, 2-chloro-
AH-034/32825008
inchi=1/c9h6cln/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6h
ofufxthgzwiddb-uhfffaoysa-
2-chloroquinoline, 99%
AKOS000120670
A8501
2-chloro-quinoline
CHEMBL2042580
chloroquinoline
5-20-07-00312 (beilstein handbook reference)
unii-ux7rin8gew
ux7rin8gew ,
FT-0612022
AB00798
chloroquinoline, 2-
chioroquinoline
SCHEMBL7252
DTXSID8060612
STR07222
Q-102326
mfcd00006741
quinoline, chloro-
CS-W007458
F0451-0421
sr-01000390732
SR-01000390732-1
SY001152
STL511939
AMY23216
BBL100153
Q27291324
Z104485978
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID668288Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Discovery of a new antileishmanial hit in 8-nitroquinoline series.
AID1364303Antiparasitic activity against Toxoplasma gondii after 4 days by chlorophenol red-beta-D-galactosidase based assay2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma.
AID668283Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Discovery of a new antileishmanial hit in 8-nitroquinoline series.
AID668289Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Discovery of a new antileishmanial hit in 8-nitroquinoline series.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's1 (7.14)18.2507
2000's0 (0.00)29.6817
2010's11 (78.57)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.64 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.71 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]